Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
212.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (2.381%)
Market Cap: £63.91m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Full Year Trading update

16 Jan 2025 07:00

RNS Number : 4994T
Mpac Group PLC
16 January 2025
Β 

16 January 2025

AIM: MPAC

Β 

Mpac Group plc

(''Mpac'', "Company" or "Group")

Β 

Full Year Trading update

Β 

FY24 trading performance in line with market expectations, a healthy opening order book for 2025 and good initial progress made on integrating H2 24 acquisitions

Β 

Β 

Mpac Group plc, a global leader in high-speed packaging and automation solutions, today announces a trading update (unaudited) for the year ended 31 December 2024 ("FY24").

Β 

The Board is pleased with the Group's FY24 performance and expects that it will report underlying profit before tax in line with market expectations of Β£10.5m (FY23: Β£7.1m). As anticipated, profit before tax in H2 24 was substantially above H1 24, aided by improving project margins and operational efficiencies.

Β 

The Group successfully executed the acquisitions of BCA Automation and CSi Palletising in H2 24 (the "Acquisitions"). The Acquisitions have continued to perform in line with the Board's expectations. The integration is progressing well and according to plan.

Β 

After the completion of the Acquisitions, the Group closes FY24 with net debt of Β£37.0m (FY23: net cash Β£2.1m) and a reduction in working capital to Β£7.0m (FY23: Β£13.2m), which includes circa Β£8.0m of invoiced receivables, due in 2024, most of which has been received in early January 2025. The Group remains on track to bring net debt down to less than 1 times EBITDA by the end of 2025.

Β 

Quote activity and the prospect pipeline within the growth sectors in which Mpac operates of Healthcare and Food and Beverage continues to be strong and following the Acquisitions, the Group ended FY24 with an increased value of the closing order book at c.Β£111.0m (FY23: Β£72.5m) providing good coverage over 2025 forecast revenue.Β 

Β 

With an increasingly diverse prospect pipeline and order book and good quote activity, as well as a stronger offering through combined product lines from our existing and acquired businesses, the Group is well placed to deliver on market expectations for the current financial year and beyond. The Board remains confident that the Group will continue progressing its long-term growth strategy.

Β 

Adam Holland, Chief Executive, commented:

Β 

We are pleased with full year 2024 financial performance, which is in line with market expectations. 2024 has proved to be a transformational year for the Group, with the acquisitions of CSi, BCA and Siga Vision providing the platform for a step change in scale and profitability, accelerating our progress towards our strategic objectives. The acquisitions materially diversify the Group's portfolio enabling the Group to provide a fuller line offering, as well as access to new customer relationships providing a platform for continued robust organic growth.

Β 

We would like to thank shareholders for their support of the acquisition of CSi and their ongoing support as we head into 2025. We anticipate reporting for 2024 record levels of revenue, with underlying profit before tax breaking through the Β£10m mark for the first time. We start 2025 with a larger and more diverse order book from our resilient end markets providing a high level of coverage over forecast revenue, supporting delivery of our expectations for further growth in the year ahead.''

Β 

The Group's full year results for the year ended 31 December 2024 are expected to be announced in the week commencing 28 April 2025, allowing for the additional time required to complete the first audit of the enlarged Group following the recent significant acquisitions.

Β 

Β 

For further information, please contact:

Mpac Group plc

Adam Holland, Chief Executive

Will Wilkins, Chief Financial Officer

Tel: +44(0)24 7642 1100

Shore Capital (Nominated Adviser & Broker)

Advisory

Patrick Castle

Sophie Collins

Broking

Henry Willcocks

Β 

Β 

Tel: +44(0)20 7408 4050

Β 

Panmure LiberumΒ (Joint Broker)

EdwardΒ Mansfield

Will King

Anake Singh

Β 

Hudson Sandler (Financial PR)

Nick Lyon

Nick Moore

Francesca Rosser

Tel: +44 (0) 20 3100 2000

Β 

Β 

Β 

Β 

Tel: +44 (0) 20 7796 4133

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTGPUCCGUPAGMA
Date   Source Headline
2nd Mar 20104:01 pmRNSDirector/PDMR Shareholding
1st Mar 20105:25 pmRNSDirector/PDMR Shareholding
26th Feb 20107:00 amRNSPreliminary Results
19th Feb 20107:00 amRNSNotice of Results
23rd Oct 20098:30 amRNSInterim Management Statement
28th Aug 20097:00 amRNSInterim Results
25th Aug 20097:00 amRNSNotification of Interim Results
27th Apr 200911:35 amRNSDoc re. Annual General Meeting Resolutions
24th Apr 20092:00 pmRNSInterim Management Statement
27th Feb 20094:21 pmRNSDirector/PDMR Shareholding
27th Feb 20097:00 amRNSFinal Results
19th Feb 200911:24 amRNSNotice of Results
26th Jan 20096:30 pmRNSHolding(s) in Company
8th Jan 20096:25 pmRNSHolding(s) in Company
5th Dec 200811:19 amRNSDirectorate Change
3rd Dec 20081:53 pmRNSSale of the Saunderton Property
1st Dec 200812:11 pmRNSHolding(s) in Company
7th Nov 200812:06 pmRNSHolding(s) in Company
17th Oct 200811:01 amRNSInterim Management Statement
6th Oct 20086:20 pmRNSHolding(s) in Company
15th Sep 20083:33 pmRNSHolding(s) in Company
28th Aug 20087:00 amRNS2008 HALF-YEAR ANNOUNCEMENT
18th Jun 20082:25 pmRNSBoard Changes
28th Apr 200811:09 amRNSDoc re. AGM
25th Apr 20081:54 pmRNSInterim Management Statement
4th Apr 20083:07 pmRNSHolding(s) in Company
19th Mar 200811:07 amRNSDoc re. AGM Result
18th Mar 20081:45 pmRNSResult of General Meeting
29th Feb 20082:06 pmRNSDirector/PDMR Shareholding
29th Feb 20087:02 amRNSGrant of a Call Option
29th Feb 20087:01 amRNSPreliminary Results
25th Jan 20089:59 amRNSDirectorate Change
23rd Jan 20086:23 pmRNSHolding(s) in Company
2nd Jan 20085:46 pmRNSHolding(s) in Company
2nd Jan 20085:03 pmRNSHolding(s) in Company
21st Nov 20077:00 amRNSHolding(s) in Company
25th Oct 20072:05 pmRNSBoard Change
21st Sep 20073:16 pmRNSHolding(s) in Company
18th Sep 20074:12 pmRNSHolding(s) in Company
7th Sep 20071:12 pmRNSHolding(s) in Company
31st Aug 20077:01 amRNSInterim Results
30th Aug 200712:17 pmRNSSale of Nottingham Site
9th Aug 20074:38 pmRNSHolding(s) in Company
18th Jul 20077:00 amRNSConditional Sale - Saunderton
9th Jul 20074:05 pmRNSHolding(s) in Company
14th May 20075:17 pmRNSHolding(s) in Company
4th May 20075:37 pmRNSDirector/PDMR Shareholding
27th Apr 20073:39 pmRNSDoc re. AGM Resolutions
27th Apr 20072:00 pmRNSAGM Statement
24th Apr 20073:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.